Sonoma Pharmaceuticals, Inc. - SNOA

Sector: Healthcare · Industry: Surgical & Medical Instruments & Apparatus
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$131K
QoQ value delta ($000)
-$9K (-6.43%)
Implied price effect (QoQ)
-43.01%
Shares
Total shares
110,783
QoQ shares delta
+43,314 (+64.2%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SNOA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 14 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
RENAISSANCE TECHNOLOGIES LLC 49 40,468 0.0%
GEODE CAPITAL MANAGEMENT, LLC 32 26,787 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 23 18,787 0.0%
McKinley Carter Wealth Services, Inc. 13 11,193 0.0%
UBS Group AG 9 7,808 0.0%
Global Retirement Partners, LLC 3 2,548 0.0%
MORGAN STANLEY 2 2,000 0.0%
DANSKE BANK A/S 0 1 0.0%
VANGUARD FIDUCIARY TRUST CO 0 100 0.0%
CWM, LLC 0 1 0.0%
OSAIC HOLDINGS, INC. 0 500 0.0%
Quaker Wealth Management, LLC 0 3 0.0%
BlackRock, Inc. 0 113 0.0%
BARCLAYS PLC 0 459 0.0%
HARBOUR INVESTMENTS, INC. 0 15 0.0%